Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Current Pharmaceutical Biotechnology|December 17, 2008
Monoclonal antibodies--regulatory challengesChristian K SchneiderNew Biotechnology|June 4, 2009
How to systematically evaluate immunogenicity of therapeutic proteins - regulatory considerationsEva-Maria Jahn, Christian K SchneiderNature Reviews. Drug Discovery|November 1, 2008
Typical pitfalls in applications for marketing authorization of biotechnological products in EuropeChristian K Schneider, Gabriele Schäffner-DallmannHuman Gene Therapy Methods|July 28, 2017
Development of the First World Health Organization Lentiviral Vector Standard: Toward the Production Control and Standardization of Lentivirus-Based Gene Therapy ProductsYuan Zhao, Hannah Stepto, Christian K SchneiderCurrent Drug Safety|July 10, 2010
Immunogenicity and its impact on benefit/risk considerations in the authorisation of biopharmaceuticalsIsabel C Büttel, Katrin Völler, Christian K Schneider, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 5, 2013
Development and regulation of biosimilars: current status and future challengesAsterios S Tsiftsoglou, Sol Ruiz, Christian K SchneiderTrends in Molecular Medicine|September 29, 2014
A roadmap toward clinical translation of genetically-modified stem cells for treatment of HIVMohamed Abou-El-Enein, Gerhard Bauer, Petra Reinke, et al.Blood|October 10, 2014
Biosimilars: the science of extrapolationMartina Weise, Pekka Kurki, Elena Wolff-Holz, et al.Journal of Neuroimmunology|June 30, 2004
Antigen recognition properties of a Vgamma1.3Vdelta2-T-cell receptor from a rare variant of polymyositisKlaus Dornmair, Christian K Schneider, Joachim Malotka, et al.Molecular Therapy. Methods & Clinical Development|November 6, 2024
What's in a word? Defining "gene therapy medicines"Maren von Fritschen, Ewa Janosz, Constanze Blume, et al.Pageof 3